Review: taking Keppra and Mucinex together


Summary

Drug interactions are reported among people who take Keppra and Mucinex together. This review analyzes the effectiveness and drug interactions between Keppra and Mucinex. It is created by eHealthMe based on reports of 110 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Keppra and Mucinex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 24,568 users)

Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 5,919 users)

On Aug, 23, 2016

110 people who take Keppra, Mucinex are studied.


Number of reports submitted per year:

Keppra and Mucinex drug interactions.

Drug effectiveness over time:

Keppra:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Keppra:
  • female: 50.0% - (1 of 2 people)
  • male: 100.0% - (2 of 2 people)
Mucinex:
  • female: 50.0% - (1 of 2 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Keppra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Mucinex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • respiratory failure
1 - 6 months:
  • malignant neoplasm progression
6 - 12 months:
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
  • constipation
  • cough
  • crying
  • cyanosis
  • diarrhoea
  • ear congestion
  • failure to thrive
1 - 2 years:
  • constipation
  • cough
  • crying
  • cyanosis
  • diarrhoea
  • ear congestion
  • failure to thrive
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
5 - 10 years:
  • aggression
  • appendicitis
  • screaming
  • suicidal ideation
  • verbal abuse
10+ years:
  • dizziness
  • vomiting
not specified:
  • cough
  • convulsion
  • diarrhoea
  • pleural effusion
  • pneumonia
  • anxiety
  • constipation
  • nausea
  • dyspnoea
  • pyrexia

Most common drug interactions by gender *:

female:
  • cough
  • convulsion
  • pneumonia
  • anxiety
  • back pain
  • nausea
  • asthenia
  • dyspnoea
  • fatigue
  • headache
male:
  • cough
  • constipation
  • diarrhoea
  • irritability
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
  • crying
  • cyanosis
  • ear congestion

Most common drug interactions by age *:

10-19:
  • constipation
  • convulsion
  • dizziness
  • drug eruption
  • dysphagia
  • gianotti-crosti syndrome
  • hepatic enzyme increased
  • hepatitis
  • hepatomegaly
  • infection
20-29:
  • convulsion
  • abdominal pain
  • anhedonia
  • anxiety
  • bile duct stone
  • brucellosis
  • chest pain
  • cholecystitis chronic
  • constipation
  • diarrhoea
30-39:
  • dyspnoea
  • vomiting
  • chest pain
  • heart rate increased
  • hypertension
  • myocardial infarction
  • abscess
  • activities of daily living impaired
  • agitation
  • anhedonia
40-49:
  • depression
  • immune reconstitution syndrome
  • progressive multifocal leukoencephalopathy
  • urinary tract infection
  • cerebrovascular accident
  • headache
  • cough
  • dehydration
  • myopathy
  • tachycardia
50-59:
  • bronchitis
  • anxiety
  • gastrointestinal haemorrhage
  • hip arthroplasty
  • incision site haemorrhage
  • pneumonia
  • respiratory failure
  • sinusitis
  • streptococcal infection
  • unresponsive to stimuli
60+:
  • cough
  • nausea
  • pleural effusion
  • pneumonia
  • fatigue
  • asthenia
  • back pain
  • death
  • deep vein thrombosis
  • gait disturbance

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Keppra and Mucinex?

Can you answer these questions?

More questions for: Keppra, Mucinex

You may be interested in these reviews

More reviews for: Keppra, Mucinex

On eHealthMe, Keppra (levetiracetam) is often used to treat epilepsy. Mucinex (guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.